This Is MS Multiple Sclerosis Knowledge & Support Community

Fampyra® now available in Ireland to treat MS walking impairment

Biogen Idec today announced that Fampyra® (prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis (MS). Fampyra is a prescription drug and is licensed for use in all types of the disease, including the progressive forms. FAMPYRA is available by way of retail pharmacy on a private payment basis. Fampyra is not currently available for reimbursement through any of the Health Service Executive’s (HSE’s) payment schemes...... Read More - http://www.ms-uk.org/ampyra

Fampyra® is a potassium channel blocker.

Magnesium also blocks potassium channels, but as an essential nutrient, it is used by the body for a multitude of purposes as the body sees fit.

People with ms are know to be Mg wasters and. even in the general population, most people are deficient.


THX1138